Loading...
Market
Which country will first adopt the MIRAI model in clinical settings by the end of 2024?
2
Resolution / Starting Odds
US • 25%
UK • 25%
Germany • 25%
Other • 25%
Public announcements from healthcare institutions, press releases
Story
MIT and ETH Zurich's MIRAI Model Validated on 1.5M Mammograms for Breast Cancer Risk Prediction
Aug 5, 2024, 04:14 PM
A significant milestone has been achieved in breast cancer risk prediction with the validation of the MIRAI model on over 1.5 million mammograms. Developed by an interdisciplinary team from MIT and ETH Zurich, the MIRAI model can assess the 5-year risk of breast cancer. This breakthrough was made possible with support from Wellcome Trust, Community Jameel, and global hospital collaborators. Additionally, a deep learning tool developed at Royal Surrey and University of Surrey has shown the capability to predict future breast cancer risk from current negative screening mammograms. The AI model can also identify different stages of Ductal carcinoma in situ from breast tissue images.
View original story
Similar markets
Japan • 25%
USA • 25%
EU • 25%
Other • 25%
United States • 25%
United Kingdom • 25%
China • 25%
Other • 25%
USA • 25%
UK • 25%
Germany • 25%
Japan • 25%
North America • 25%
Europe • 25%
Asia • 25%
None • 25%
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
UK • 25%
Germany • 25%
Canada • 25%
Other • 25%
Japan • 25%
USA • 25%
EU • 25%
Other • 25%
United States • 25%
European Union • 25%
China • 25%
Other • 25%
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
MIT • 33%
ETH Zurich • 33%
Other collaborating institution • 33%
None • 1%
United States • 25%
European Union • 25%
Japan • 25%
Canada • 25%
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%